Pfizer's experimental drug misses main goal of lung cancer trial
Pfizer said on Monday its drug for a type of lung cancer missed the main goal of a late-stage trial.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
Copyright Reuters or USA Today Network via Reuters Connect
This story was originally published June 22, 2026 at 1:40 PM.